MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • MDS Virtual Congress 2021

    Current perspectives on the management of cervical dystonia among global clinicians

    H. Jinnah, H. Ferraz, S. Standal, P. Fattahi, A. Zuzek, N. Alibhai, K. Merath (Atlanta, USA)

    Objective: The aim of this study was to gain the perspectives of clinicians who treat patients with CD in terms of assessment and treatment goals,…
  • MDS Virtual Congress 2021

    The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.

    K. Lazdovska, R. Valante (Riga, Latvia)

    Objective: To investigate the effectiveness of BoNT treatment in patients with essential blepharospasm and determine the most common reasons for discontinuation of the treatment. Background: Essential…
  • MDS Virtual Congress 2021

    Does Microneedle Use for Facial Injection of Botulinum Toxin Reduce Pain? A Systematic Literature Review

    S. Maytharakcheep (Bangkok, Thailand)

    Objective: To perform a systematic review to identify relevant literature on pain outcomes after injecting BTX with a microneedle for various facial conditions and to…
  • MDS Virtual Congress 2021

    Efficacy and safety of Botulinum toxin (BoNT) in lingual dystonia

    D. Nene, S. Cresswell (Vancouver, Canada)

    Objective: To evaluate the current evidence on the efficacy and safety of BoNT in treating lingual dystonia. Background: Lingual dystonia is a rare yet debilitating…
  • MDS Virtual Congress 2021

    Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies

    R. Rosales, L. Cuffe, B. Regnault, R. Trosch (Manila, Philippines)

    Objective: The aim of this meta-analysis of pivotal studies was to evaluate the efficacy of abobotulinumtoxinA (AboBoNT-A) in reducing pain in patients with cervical dystonia…
  • MDS Virtual Congress 2021

    COMPARISON OF ELECTROPHYSIOLOGIC AND ULTRASOUND GUIDANCE FOR ONABOTULINUM TOXIN-A INJECTIONS IN FOCAL UPPER EXTREMITY SPASTICITY AND DYSTONIA

    C. Lungu, A. Nmashie, MC. George, T. Wu, S. Shin, B. Karp, E. Considine, W. Tse, S. Frucht, C. Wu, V. Koo, G. Norato, K. Alter, M. Hallet, DM. Simpson ()

    Objective: To investigate two targeting techniques for onabotulinum toxin-A (BoNT) injection for the treatment of focal hand dystonia and upper limb spasticity: guidance with electrical…
  • MDS Virtual Congress 2021

    Approaching the lateral pterygoid muscle in botulinum toxin injections. How to avoid the maxillary artery

    S. Unal, T. Karaarslan-Turk, C. Akbostanci, E. Peker, R. Yilmaz (Ankara, Turkey)

    Objective: To investigate the course of the maxillary artery (MA) in relation to the lateral pterygoid muscle (LPM) in the Turkish population and to help…
  • MDS Virtual Congress 2021

    Dystonia gravidarum: An emerging clinical entity

    E. Donlon, P. Moloney, S. Smyth, S. Lyons, T. Lynch, E. Mcgovern (Limerick, Ireland)

    Objective: We describe a case of cervical dystonia in a 36 year-old, secundigravid, Caucasian woman at 8 weeks gestation. Background: Though uncommon, primary movement disorders…
  • MDS Virtual Congress 2021

    Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE

    P. Agarwal, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)

    Objective: This analysis evaluated the sustained effects of onabotulinumtoxinA in patients with CD who were naive or non-naive to botulinum toxin at enrollment in CD…
  • MDS Virtual Congress 2021

    Post-stroke dystonia: Three unique cases

    C. Han, L. Klebanoff, P. Magda, B. Sadoughi, S. Pullman, H. Sarva (Ny, USA)

    Objective: Describing 3 unique post-stroke dystonia cases. Background: Dystonia, the 2nd most common post-stroke movement disorder, presents commonly contralateral to the lesion, focally, and 9.5…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley